Using a similar protocol but that included HS, another group of investigators reported engraftment upon the intramuscular (1 × 106) and intravenous (2 × 106) injection of day 14 GFP-labeled iPSC-derived myogenic progenitors in uninjured dystrophin-deficient mdx mice (model for DMD) that were treated daily with immunosuppressant Busulfex [51]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.